Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1998
12/03/1998WO1998054182A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
12/03/1998WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
12/03/1998WO1998054166A1 A new salt
12/03/1998WO1998054152A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/03/1998WO1998053856A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053838A2 A soluble laminin receptor precursor and methods to inhibit its interactions
12/03/1998WO1998053834A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998WO1998053833A1 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
12/03/1998WO1998053825A1 Analgesic drug composition containing a capsaicinoid and potentiator therefor
12/03/1998WO1998053824A1 Novel process
12/03/1998WO1998053823A1 5-HT1A AND 5-HT1Dα ANTAGONISTS
12/03/1998WO1998053820A1 Treatment of schizophrenia and psychosis
12/03/1998WO1998053814A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies
12/03/1998WO1998045331A3 Anti-vegf antibodies
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998038994A3 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998CA2291856A1 Cyclic crf antagonist peptides
12/03/1998CA2291778A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998CA2291720A1 Pharmaceutical compositions comprising a soluble laminin receptor precursor of a compound which blocks the interaction of the laminin receptor precursor and prpsc or prpc
12/03/1998CA2291674A1 5-ht1a and 5-ht1d.alpha. antagonists
12/03/1998CA2291335A1 Analgesic drug composition containing a capsaicinoid and potentiator therefor
12/03/1998CA2291254A1 1,6-naphthyridine anti-convulsants
12/03/1998CA2291251A1 Novel process
12/03/1998CA2290682A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998CA2290675A1 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
12/03/1998CA2290070A1 Salts of aromatic sulphonic acids
12/03/1998CA2289578A1 Spiro-quinuclidine derivatives, their preparation and use
12/03/1998CA2289576A1 Azacyclooctane and heptane derivatives, their preparation and use in therapy
12/03/1998CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998CA2288810A1 Ergoline derivatives and their use as somatostatin receptor antagonists
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881224A1 5-HT1A and 5-HT1D alpha antagonists
12/02/1998EP0881216A1 Solid methylphenidate, its preparation and use in medicine
12/02/1998EP0880558A1 Combinatorial process for preparing substituted indane libraries
12/02/1998EP0880542A2 Substrates and inhibitors for cysteine protease ich-1
12/02/1998EP0880529A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880528A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880526A1 Heterocycle-condensed morphinoid derivatives (ii)
12/02/1998EP0880524A1 New triazolopurines, method of preparing them and their use as drugs
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880522A1 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME
12/02/1998EP0880512A1 Novel aromatic piperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions, and use thereof as drugs
12/02/1998EP0880502A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
12/02/1998EP0880363A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
12/02/1998EP0880358A1 Inhibitors of cyclophilin rotamase activity
12/02/1998EP0880352A2 Stabilization of naloxonhydrochlorid
12/02/1998EP0880350A1 Multiple sclerosis treatment
12/02/1998EP0869975A4 Assay for and uses of peptide hormone receptor ligands
12/02/1998EP0787206A4 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS
12/02/1998EP0681473B1 Compositions containing tandospirone or its analogs
12/02/1998EP0544779B1 Heterocyclic compounds and their preparation and use
12/02/1998CN1200729A Optically active phenyl pyrimidine derivative as analgesic agent
12/02/1998CN1200670A Pharmaceutical compositions contg. hydroximic acid derivatives
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1040979C Antipsychotic method
12/02/1998CA2238580A1 Cell adhesion inhibitors
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844079 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
12/01/1998US5844077 Use of conantokins for producing analgesia or for neuroprotection
12/01/1998US5844074 Cyclic CRF agonists
12/01/1998US5844003 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
12/01/1998US5843999 2-phenylazulene derivatives and a manufacturing method of these compounds
12/01/1998US5843997 Excitatory amino acid receptor antagonists
12/01/1998US5843996 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843989 C4 -amide substituted compounds and their use as therapeutic agents
12/01/1998US5843988 Cyclopropachromencarboxylic acid derivatives
12/01/1998US5843986 Tricyclic amide compounds
12/01/1998US5843977 (3-heteroaryl-1-pyrrolidinyl) alkoxy!-3,4-dihydro-1(2H)-naphthalenones and related compounds and their therapeutic utility
12/01/1998US5843975 Oxazolidinone derivatives, their preparation and therapeutical use
12/01/1998US5843972 Heterocyclic β-adrenergic agonists
12/01/1998US5843971 1, 1-BIS (heteroazolyl) alkane derivatives and their use as neuroprotective agents
12/01/1998US5843966 Piperidine derivatives
12/01/1998US5843961 Method and composition for treating erectile dysfunction
12/01/1998US5843960 Inhibitors of rotamase enzyme activity
12/01/1998US5843949 1-(1H-indolyloxyalkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics
12/01/1998US5843935 Protein kinase C inhibitors
12/01/1998US5843934 Uses of estrogen compounds for the treatment of disease
12/01/1998US5843932 Therapeutic methods and delivery systems utilizing sex steroid precursors
12/01/1998US5843914 Neurturin and related growth factors
12/01/1998US5843910 Colchicine derivatives and the therapeutical use thereof
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843775 Human dorsal tissue affecting factor (noggin) and nucleic acids encoding same
12/01/1998US5843695 Method for decomposing amyloid protein precursor and amyloid β-protein
12/01/1998US5843641 Methods for the daignosis, of familial amyotrophic lateral sclerosis
12/01/1998US5843465 Emulsion formulation
12/01/1998CA2104381C Production and use of butyrylcholinesterase
12/01/1998CA2060139C Triazole derivative
12/01/1998CA2026216C Optically active benzyl alcohol compound and the use thereof
12/01/1998CA2009593C Medicament containing dihydrolipoic acid as active substance
11/1998
11/30/1998CA2233554A1 Novel compounds
11/27/1998CA2232817A1 Novel compounds
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052963A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
11/26/1998WO1998052946A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
1 ... 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 ... 1833